Ryvu Therapeutics SA
WSE:RVU
| US |
|
VAALCO Energy Inc
NYSE:EGY
|
Energy
|
| US |
A
|
Alpha Metallurgical Resources Inc
NYSE:AMR
|
Metals & Mining
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| CN |
|
Daqo New Energy Corp
NYSE:DQ
|
Semiconductors
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
Snap Inc
NYSE:SNAP
|
Media
|
| US |
|
PBF Energy Inc
NYSE:PBF
|
Energy
|
| US |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
Biotechnology
|
| US |
|
Target Hospitality Corp
NASDAQ:TH
|
Hotels, Restaurants & Leisure
|
| UK |
|
Ferroglobe PLC
NASDAQ:GSM
|
Metals & Mining
|
| US |
|
R C M Technologies Inc
NASDAQ:RCMT
|
Professional Services
|
| US |
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
Pharmaceuticals
|
| US |
|
Apple Inc
NASDAQ:AAPL
|
Technology
|
| US |
|
NVIDIA Corp
NASDAQ:NVDA
|
Semiconductors
|
| US |
|
Clearfield Inc
NASDAQ:CLFD
|
Communications
|
| US |
|
Enphase Energy Inc
NASDAQ:ENPH
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
39.7
64.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
|
|
VAALCO Energy Inc
NYSE:EGY
|
US |
|
A
|
Alpha Metallurgical Resources Inc
NYSE:AMR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Daqo New Energy Corp
NYSE:DQ
|
CN |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
Snap Inc
NYSE:SNAP
|
US |
|
|
PBF Energy Inc
NYSE:PBF
|
US |
|
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
|
Ferroglobe PLC
NASDAQ:GSM
|
UK |
|
|
R C M Technologies Inc
NASDAQ:RCMT
|
US |
|
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
US |
|
|
Apple Inc
NASDAQ:AAPL
|
US |
|
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
|
Clearfield Inc
NASDAQ:CLFD
|
US |
|
|
Enphase Energy Inc
NASDAQ:ENPH
|
US |
This alert will be permanently deleted.
Ryvu Therapeutics SA
Retained Earnings
Ryvu Therapeutics SA
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Retained Earnings
-zł15.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Inno-Gene SA
WSE:IGN
|
Retained Earnings
zł2.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
35%
|
|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Retained Earnings
-zł3.1m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-114%
|
CAGR 10-Years
N/A
|
|
|
S
|
Selvita SA
WSE:SLV
|
Retained Earnings
zł202.8m
|
CAGR 3-Years
83%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ryvu Therapeutics SA
Glance View
Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 186 full-time employees. The company went IPO on 2011-07-14. The firm is active in the pharmaceutical and biotechnology fields. The company operates through two business segments. The Innovative segment develops new drugs mainly for oncology and central nervous system diseases. The Services segment is engaged in the research and development activities, such as introducing substances on the market, client service and reducing the risk. The Company’s portfolio encompasses projects, including kinesis inhibitors platform, the platform of the metabolism for the cancer and epigenetic, among others. Ryvu Therapeutics SA is active in the domestic market and internationally, such as in the United States. The company operates through unit Ardigen SA and SORS Holdings Ltd.
See Also
What is Ryvu Therapeutics SA's Retained Earnings?
Retained Earnings
-15.9m
PLN
Based on the financial report for Sep 30, 2024, Ryvu Therapeutics SA's Retained Earnings amounts to -15.9m PLN.
You don't have any saved screeners yet
